-+ 0.00%
-+ 0.00%
-+ 0.00%

KYMERA THERAPEUTICS INC - KT-621 WELL-TOLERATED WITH NO SERIOUS ADVERSE EVENTS REPORTED

Reuters·12/08/2025 12:00:02

Please log in to view news